Genetron Health to Present at CNBC East Tech West Conference
November 12 2020 - 5:30AM
Genetron Holdings Limited (“Genetron Health” or the “Company”,
NASDAQ: GTH), a leading precision oncology platform company in
China that specializes in offering molecular profiling tests, early
cancer screening products and companion diagnostics development,
today announced that management will present at the CNBC East Tech
West Conference to be held in Guangzhou, China, Nov. 17-18, 2020.
On Wednesday Nov. 18, Sizhen Wang, Co-Founder and Chief
Executive Officer of Genetron Health will participate in the
following:
- Panel discussion entitled,
“Innovative Ways in Tackling Life Threatening Disease,” at 9:30 am
Beijing Time
For more information, please
visit:https://ir.genetronhealth.com/investors.https://www.cnbcevents.com/easttechwest/
About Genetron Holdings Limited
Genetron Holdings Limited (“Genetron Health” or the “Company”)
is a leading precision oncology platform company in China that
specializes in cancer molecular profiling and harnesses advanced
technologies in molecular biology and data science to transform
cancer treatment. The Company has developed a comprehensive
oncology portfolio that covers the entire spectrum of cancer
management, addressing needs and challenges from early screening,
diagnosis and treatment recommendations, as well as continuous
disease monitoring and care. Genetron also partners with global
biopharmaceutical companies and offers customized services and
products. For more information, please visit
ir.genetronhealth.com.
Safe Harbor Statement
This press release contains forward-looking statements. These
statements are made under the “safe harbor” provisions of the U.S.
Private Securities Litigation Reform Act of 1995. Statements that
are not historical facts, including statements about the Company’s
beliefs and expectations, are forward-looking statements.
Forward-looking statements involve inherent risks and
uncertainties, and a number of factors could cause actual results
to differ materially from those contained in any forward-looking
statement. In some cases, forward-looking statements can be
identified by words or phrases such as “may”, “will,” “expect,”
“anticipate,” “target,” “aim,” “estimate,” “intend,” “plan,”
“believe,” “potential,” “continue,” “is/are likely to” or other
similar expressions. Further information regarding these and other
risks, uncertainties or factors is included in the Company’s
filings with the SEC. All information provided in this press
release is as of the date of this press release, and the Company
does not undertake any duty to update such information, except as
required under applicable law.
Investor Relations ContactsUS:Hoki LukHead of
Investor RelationsEmail: hoki.luk@genetronhealth.comPhone: +1 (408)
204-5343
Stephanie CarringtonWestwicke, an ICR CompanyEmail:
Stephanie.Carrington@westwicke.comPhone: +1 (646) 277-1282
Asia:Bill ZimaICR, Inc.Email:
bill.zima@icrinc.comGenetronIR@icrinc.com
Media Relations ContactEdmond
LococoICREdmond.Lococo@icrinc.comMobile: +86
138-1079-1408genetron.pr@icrinc.com
Yuan TaoYuan.tao@genetronhealth.com
Genetron (NASDAQ:GTH)
Historical Stock Chart
From Aug 2024 to Sep 2024
Genetron (NASDAQ:GTH)
Historical Stock Chart
From Sep 2023 to Sep 2024